| |
| |
|
| Insider
Information: |
Stanker James H |
| Relationship: |
|
| City: |
Sykesville |
| State: |
MD |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
54,238 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$8,753 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
54,238 |
|
|
| Total
Value |
$8,753 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
2
|
0
|
|
Stock
price went up :
|
1
|
0
|
| Stock
price went down : |
1
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
 -10.2%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
GSE Systems Inc |
GVP |
Director |
2019-06-11 |
48,118 |
2016-12-08 |
0 |
Premium* |
|
|
Processa Pharmaceuticals, Inc. |
PCSA |
|
2024-01-01 |
6,120 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
15 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PCSA |
Processa Pharmaceuticals,... |
Chief Financial Officer |
• • – |
2024-01-01 |
4 |
D |
$2.79 |
$1,445 |
D/D |
(518) |
6,120 |
0 |
- |
|
| PCSA |
Processa Pharmaceuticals,... |
Chief Financial Officer |
• • – |
2024-01-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,675 |
6,638 |
0 |
- |
|
| PCSA |
Processa Pharmaceuticals,... |
Chief Financial Officer |
• • – |
2023-10-12 |
4 |
A |
$0.33 |
$4,950 |
D/D |
15,000 |
99,250 |
0 |
- |
|
| PCSA |
Processa Pharmaceuticals,... |
Chief Financial Officer |
• • – |
2023-10-10 |
4 |
A |
$0.24 |
$5,400 |
D/D |
22,500 |
84,250 |
0 |
- |
|
| PCSA |
Processa Pharmaceuticals,... |
Chief Financial Officer |
• – – |
2023-02-09 |
4 |
A |
$0.80 |
$10,000 |
D/D |
12,500 |
61,750 |
0 |
- |
|
| PCSA |
Processa Pharmaceuticals,... |
Chief Financial Officer |
• – – |
2022-08-05 |
4 |
D |
$3.17 |
$7,805 |
D/D |
(2,462) |
49,250 |
0 |
- |
|
| PCSA |
Processa Pharmaceuticals,... |
Chief Financial Officer |
• – – |
2022-08-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,601 |
51,712 |
0 |
- |
|
| PCSA |
Processa Pharmaceuticals,... |
Chief Financial Officer |
• – – |
2021-08-05 |
4 |
A |
$0.00 |
$0 |
D/D |
7,601 |
44,111 |
0 |
- |
|
| PCSA |
Processa Pharmaceuticals,... |
Chief Financial Officer |
• – – |
2021-06-21 |
4 |
B |
$6.81 |
$6,810 |
D/D |
1,000 |
36,510 |
2.74 |
% |
|
| PCSA |
Processa Pharmaceuticals,... |
Chief Financial OfficerOfficer |
• – – |
2020-10-02 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
41,248 |
|
% |
|
| PCSA |
Processa Pharmaceuticals,... |
Chief Financial Officer |
• – – |
2020-10-01 |
4 |
B |
$2.10 |
$12,600 |
D/D |
6,000 |
47,248 |
2.74 |
% |
|
| GVP |
GSE Systems Inc |
Director |
– • – |
2019-06-11 |
4 |
A |
$0.00 |
$0 |
D/D |
25,316 |
48,118 |
0 |
- |
|
| GVP |
GSE Systems Inc |
Director |
– • – |
2018-06-12 |
4 |
A |
$0.00 |
$0 |
D/D |
7,911 |
22,802 |
0 |
- |
|
| GVP |
GSE Systems Inc |
Director |
– • – |
2017-06-12 |
4 |
A |
$0.00 |
$0 |
D/D |
9,275 |
14,891 |
0 |
- |
|
| GVP |
GSE Systems Inc |
Director |
– • – |
2016-12-08 |
4 |
A |
$0.00 |
$0 |
D/D |
5,616 |
5,616 |
0 |
- |
|
15 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
